Nanosuspension-based Ocular Therapeutics for Infection Control: Integrating Mucin Interactions and Tear Film Dynamics
Open Access
- 9 September 2026
- journal article
- review article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (7) , 278
Abstract
Ocular infections can affect the ocular surface and adnexal structures, intraocular structures, or both. Infections of the ocular surface and adnexa oftenKeywords
Funding Information
- Manipal Academy of Higher Education, Manipal
This publication has 228 references indexed in Scilit:
- Targeting Tetraspanins at Cell Interfaces: Functional Modulation and Exosome‐Based Drug Delivery for Precise Disease TreatmentChemMedChem, 2024
- Assessment of Mucin-Associated Gene Expression Levels on the Ocular Surface2024
- Ocular contact lenses: smart materials for biomedical applicationsPolymer Bulletin, 2023
- Recent Advances in Mucoadhesive Interface Materials, Mucoadhesion Characterization, and TechnologiesAdvanced Materials Interfaces, 2022
- An ion‐paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infectionBioengineering & Translational Medicine, 2021
- Mass spectrometry‐based tear proteomics for noninvasive biomarker discoveryMass Spectrometry Reviews, 2021
- Glycobiology of the ocular surface: mucins and lectinsJapanese Journal of Ophthalmology, 2013
- Interfacial Interaction between Transmembrane Ocular Mucins and Adhesive Polymers and Dendrimers Analyzed by Surface Plasmon ResonancePharmaceutical Research, 2012
- Assessing Mucin Expression and Function in Human Ocular Surface Epithelia In Vivo and In Vitro2011
- Barriers in Ocular Drug Delivery2008